Task: Answer the multiple-choice question.
Query: Which compound exhibits a -9.889% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: CCC(=O)Nc1cccc(NC(=O)CSc2nnc(C(C)C)n2CC)c1
b: Cc1noc(C)c1COc1ccccc1C(=O)NCCc1ccc(S(N)(=O)=O)cc1
Answer: a. CCC(=O)Nc1cccc(NC(=O)CSc2nnc(C(C)C)n2CC)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)Nc1cccc(NC(=O)CSc2nnc(C(C)C)n2CC)c1
CCC(=O)Nc1cccc(NC(=O)CSc2nnc(C(C)C)n2CC)c1
N-[3-[[2-[(4-ethyl-5-propan-2-yl-1,2,4-triazol-3-yl)sulfanyl]acetyl]amino]phenyl]propanamide